Home›People›Scott Gottlieb
SG

Scott Gottlieb

Director at Unitedhealth Group. Also a director at Aseko.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Sep 24, 2026·Suggest an edit

About Scott Gottlieb

Scott Gottlieb is a director at Unitedhealth Group.

Form D filings name Scott Gottlieb as a director at Aseko.

Scott Gottlieb reports to the SEC as a director of 7 public companies, including Tempus AI (TEM), Illumina (ILMN) and Pfizer (PFE).

Scott Gottlieb first appears on SEC filings in 2007.

Experience

This experience comes from SEC filings. The years are when the filings name Scott Gottlieb in the role, so the role may have started earlier or lasted longer.

Unitedhealth Group Inc.
Director
2025 – 2026 · Public company (UNH)
Tempus AI, Inc.
Director
2024 – 2026 · Public company (TEM)
Illumina, Inc.
Director
2020 – 2026 · Public company (ILMN)
Pfizer Inc.
Director
2019 – 2026 · Public company (PFE)
CombiMatrix Corp
Director
2009 – 2016 · Public company (CBMX)
Aseko, Inc.
Director
2013 – 2016 · Atlanta, GA
Through Glytec, provides insulin management software to healthcare providers.
Targeted Medical Pharma, Inc.
Director
2013 · Public company (TRGM)
Molecular Insight Pharmaceuticals, Inc.
Director
2007 – 2010 · Public company (MIPI)

Key Colleagues at Startups

The people Scott Gottlieb works with at each company, as listed on that company's latest Form D.

Aseko, Inc. · Form D, Mar 21, 2016
JB
John Beneke
Executive officer
RL
Robert Leonard
Executive officer and director
CP
Cheryl Pegus
Director
RB
Robby Booth
Executive officer
RM
Raymie McFarland
Executive officer
Tim Fischell
Tim Fischell
Director
JD
Joseph Diver
Executive officer
LV
Lynn Vogel
Director
PT
Phillip Torrence
Asst. Secretary
PF
MN
DF
Daniel Frank
Executive officer and director
MP
Megan Pietropaolo
Executive officer

Sources

  1. SECAseko, Inc. Form D, filed Mar 21, 2016
  2. SECForms 3, 4 and 5 filed by Scott Gottlieb (SEC filer 1411359)